Virax Biolabs Group (VRAX) Revenue & Revenue Breakdown
Virax Biolabs Group Revenue Highlights
Latest Revenue (Y)
$8.56K
Latest Revenue (Q)
$76.50K
Virax Biolabs Group Revenue by Period
Virax Biolabs Group Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-03-31 | $8.56K | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-03-31 | $123.82K | 23.97% |
| 2020-03-31 | $99.88K | - |
Virax Biolabs Group generated $8.56K in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Virax Biolabs Group Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $76.50K | 2631.17% |
| 2023-03-31 | $2.80K | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2022-09-30 | $5.76K | 100.00% |
| 2022-06-30 | - | -100.00% |
| 2022-03-31 | $-92.86K | -400.00% |
| 2021-12-31 | $30.95K | 100.00% |
| 2021-09-30 | - | -100.00% |
| 2021-06-30 | $30.95K | -71.81% |
| 2021-03-31 | $109.82K | 339.83% |
| 2020-12-31 | $24.97K | 78.35% |
| 2020-09-30 | $14.00K | -43.93% |
| 2020-06-30 | $24.97K | - |
| 2020-03-31 | $24.97K | - |
Virax Biolabs Group generated $76.50K in revenue during Q2 2024, up 2631.17% compared to the previous quarter, and up -82.38% compared to the same period a year ago.
Virax Biolabs Group Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| UNCY | Unicycive Therapeutics | $675.00K | - |
| BDRX | Biodexa Pharmaceuticals | $381.00K | $41.50K |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| NRBO | NeuroBo Pharmaceuticals | $7.00K | - |
| PXMD | PaxMedica | - | - |
| REVB | Revelation Biosciences | - | - |
| HILS | Tharimmune | - | - |
| ALLR | Allarity Therapeutics | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| KPRX | Kiora Pharmaceuticals | - | $20.00K |
| CDIO | Cardio Diagnostics | - | $7.87K |
| BWV | Onconetix | - | - |
VRAX Revenue FAQ
What is Virax Biolabs Group’s yearly revenue?
Virax Biolabs Group's yearly revenue for 2023 was $8.56K, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021. VRAX's yearly revenue for 2021 was $123.82K, representing an increase of 23.97% compared to 2020.
What is Virax Biolabs Group’s quarterly revenue?
Virax Biolabs Group's quarterly revenue for Q2 2024 was $76.5K, a 2631.17% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.8K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). VRAX's quarterly revenue for Q3 2023 was $0, a -100.00% decrease from the previous quarter (Q2 2023), and a -100.00% decrease year-over-year (Q3 2022).
What is Virax Biolabs Group’s revenue growth rate?
Virax Biolabs Group's revenue growth rate for the last 3 years (2021-2023) was -93.09%